Evidence map›Paper›PMID 36193595›Full record

ArticleChemical communications (Cambridge, England)2022

Biochemical characterization of a cyanobactin arginine-

Claudia Clemente, Nicholas Johnson, Xiaodan Ouyang, Rafael V Popin, Sergio Dall'Angelo, Matti Wahlsten, Jouni Jokela, Alessandro Colombano, Brunello Nardone, David P Fewer and 1 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical communications (Cambridge, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Biosynthesis of guanidine-containing natural products in cyanobacteria.Journal of industrial microbiology & biotechnology · 2024
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Claudia ClementeInstitute of Medical Sciences, University of Aberdeen, Ashgrove Road West, Foresterhill Aberdeen AB25 2ZD, UK. w.houssen@abdn.ac.uk.ORCID http://orcid.org/0000-0001-5016-4757
Nicholas JohnsonInstitute of Medical Sciences, University of Aberdeen, Ashgrove Road West, Foresterhill Aberdeen AB25 2ZD, UK. w.houssen@abdn.ac.uk.ORCID http://orcid.org/0000-0001-6608-4348
Xiaodan OuyangDepartment of Microbiology, University of Helsinki, P.O.Box 56, Viikki Biocenter, Viikinkaari 9, 00014, Finland. david.fewer@helsinki.fi.ORCID http://orcid.org/0000-0002-1503-7186
Rafael V PopinDepartment of Microbiology, University of Helsinki, P.O.Box 56, Viikki Biocenter, Viikinkaari 9, 00014, Finland. david.fewer@helsinki.fi.ORCID http://orcid.org/0000-0003-0427-0326
Sergio Dall'AngeloInstitute of Medical Sciences, University of Aberdeen, Ashgrove Road West, Foresterhill Aberdeen AB25 2ZD, UK. w.houssen@abdn.ac.uk.ORCID http://orcid.org/0000-0001-9377-0474
Matti WahlstenDepartment of Microbiology, University of Helsinki, P.O.Box 56, Viikki Biocenter, Viikinkaari 9, 00014, Finland. david.fewer@helsinki.fi.ORCID http://orcid.org/0000-0002-4107-1695
Jouni JokelaDepartment of Microbiology, University of Helsinki, P.O.Box 56, Viikki Biocenter, Viikinkaari 9, 00014, Finland. david.fewer@helsinki.fi.
Alessandro ColombanoInstitute of Medical Sciences, University of Aberdeen, Ashgrove Road West, Foresterhill Aberdeen AB25 2ZD, UK. w.houssen@abdn.ac.uk.ORCID http://orcid.org/0000-0002-3685-7095
Brunello NardoneCEM Microwave Ltd, Buckingham Industrial Park, Buckingham MK18 1WA, UK.
David P FewerDepartment of Microbiology, University of Helsinki, P.O.Box 56, Viikki Biocenter, Viikinkaari 9, 00014, Finland. david.fewer@helsinki.fi.ORCID http://orcid.org/0000-0003-3978-4845
Wael E HoussenInstitute of Medical Sciences, University of Aberdeen, Ashgrove Road West, Foresterhill Aberdeen AB25 2ZD, UK. w.houssen@abdn.ac.uk.ORCID http://orcid.org/0000-0001-9653-5111
University of Aberdeen · GBUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyanobactins are linear and cyclic post-translationally modified peptides. Here we show that the prenyl-D-Arg-containing autumnalamide A is a member of the cyanobactin family. Biochemical assays demonstrate that the AutF prenyltransferase targets the guanidinium moiety in arginine and homoarginine and is a useful tool for biotechnological applications.

Indexed as

Biosynthetic PathwaysDimethylallyltranstransferaseArginineGuanidineHomoargininePeptides, CyclicArginineautumnalamidecyanobactinsDimethylallyltranstransferaseGuanidineHomoargininePeptides, Cyclic

Identifiers

PMID36193595
PMCPMC9609003
OpenAlexW4301392205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.